Search

1. Enforcement policy for extracorporeal membrane oxygenation and cardiopulmonary bypass devices during the Coronavirus disease 2019 (COVID-19) public health emergency: guidance for industry and Food and Drug Administration staff

Publication:

[Silver Spring, MD] : Center for Devices and Radiological Health, Office of Product Evaluation and Quality April 2020

Subject(s):

Cardiopulmonary Bypass -- instrumentation
Extracorporeal Membrane Oxygenation -- instrumentation
COVID-19 -- therapy
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

2. Investigational COVID-19 convalescent plasma

Publication:

Silver Spring, MD : Center for Biologics Evaluation and Research, February 11, 2021

Subject(s):

Antibodies, Viral
Blood Donors
COVID-19 -- therapy
Plasma
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

3. Investigational COVID-19 convalescent plasma

Publication:

Silver Spring, MD : Center for Biologics Evaluation and Research, January 7, 2022

Subject(s):

COVID-19 -- therapy
Immunization, Passive
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

4. COVID-19 treatment and hospitalization costs: a descriptive analysis of the FAIR Health COVID-19 Cost Tracker

Publication:

New York, NY : FAIR Health, Inc., December 15, 2021

Subject(s):

COVID-19 -- economics
COVID-19 -- therapy
Costs and Cost Analysis
Health Care Costs -- statistics & numerical data
Hospital Costs -- statistics & numerical data
Hospitalization -- economics
United States